prolactin

(redirected from HPRL)
Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

prolactin

 [pro-lak´tin]
a hormone secreted by the anterior pituitary gland that promotes the growth of breast tissue and stimulates and sustains milk production in postpartum mammals, and shows luteotropic activity in certain mammals. Called also lactogenic hormone and mammotropin.

pro·lac·tin (PRL),

(prō-lak'tin), [MIM*176760]
A protein hormone of the anterior lobe of the hypophysis that stimulates the secretion of milk and possibly, during pregnancy, breast growth.
[pro- + L. lac, lact-, milk, + -in]

prolactin

(prō-lăk′tĭn)
n.
A pituitary hormone that stimulates and maintains the secretion of milk in mammals and also plays a role in metabolism and in modulation of the immune response.

prolactin

A gonadotropic hormone encoded by PRL on chromosome 6p22.2-p21.3 and secreted by the anterior pituitary, which in females stimulates mammary gland growth and lactation after childbirth.

pro·lac·tin

(PRL) (prō-lak'tin)
A protein hormone of the anterior lobe of the hypophysis that stimulates the secretion of milk and possibly, during pregnancy, breast growth.
Compare: bioregulator
Synonym(s): lactogenic hormone.
[pro- + L. lac,lact-, milk, + -in]

prolactin

One of the PITUITARY GLAND hormones. Prolactin stimulates the development and growth of the breasts (mammary glands) and helps to start and maintain milk production at the end of pregnancy.

prolactin

see LUTEOTROPHIC HORMONE.

Prolactin

A hormone that helps the breast prepare for milk production during pregnancy.
Mentioned in: Pituitary Dwarfism

pro·lac·tin

(prō-lak'tin) [MIM*176760]
Protein hormone of anterior lobe of hypophysis that stimulates secretion of milk and possibly, during pregnancy, breast growth.
[pro- + L. lac,lact-, milk, + -in]
References in periodicals archive ?
(21), se demostro al igual que en el presente estudio, que existe una relacion positiva entre la HPRL y una puntuacion alta del SLEDAI ([mayor que o igual a] 4), en su caso en el 69% de las pacientes con LES, por lo que, se planteo la hipotesis de que la PRL y la IL-6 se acumulan en el rinon inflamado y actuan como estimulos para linfocitos T y B que se infiltran en el tejido renal, lo cual pudiera explicar el predominio de manifestaciones renales.
(14), demostraron que existia una relacion positiva entre la HPRL y el dano a organos en pacientes con LES en un 29,4%, pero que ademas, la prevalencia de manifestaciones cardiaca, renal y vascular periferica era mayor en las pacientes con HPRL; todo esto relacionado con el impacto de la PRL sobre la funcion endotelial, la sensibilidad a la insulina y la regulacion de la presion arterial.
In addition, we found no differences in the anti-dsDNA and anti-C1q levels between the hPRL and non-hPRL groups or between the small and large PRL groups.